Grantham, Mayo, Van Otterloo & Co (GMO)’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,600
Closed -$575K 712
2023
Q1
$575K Sell
5,600
-5,100
-48% -$549K ﹤0.01% 547
2022
Q4
$1.1M Sell
10,700
-1,900
-15% -$193K 0.01% 505
2022
Q3
$1.08M Sell
12,600
-11,500
-48% -$1.09M 0.01% 486
2022
Q2
$2.31M Buy
24,100
+10,300
+75% +$1M 0.01% 426
2022
Q1
$1.28M Buy
+13,800
New +$1.31M 0.01% 500
2021
Q2
Sell
-5,769
Closed -$592K 786
2021
Q1
$592K Sell
5,769
-51,100
-90% -$5.06M ﹤0.01% 674
2020
Q4
$5.16M Sell
56,869
-178,805
-76% -$13.9M 0.03% 287
2020
Q3
$14.9M Sell
235,674
-25,700
-10% -$1.91M 0.11% 121
2020
Q2
$20.2M Sell
261,374
-19,400
-7% -$1.42M 0.15% 92
2020
Q1
$19.5M Buy
280,774
+9,566
+4% +$874K 0.16% 88
2019
Q4
$28.1M Buy
271,208
+51,600
+23% +$4.93M 0.19% 92
2019
Q3
$19.6M Buy
219,608
+96,534
+78% +$8.65M 0.14% 114
2019
Q2
$11.2M Buy
123,074
+26,800
+28% +$2.26M 0.08% 173
2019
Q1
$8.02M Buy
96,274
+88,874
+1,201% +$6.62M 0.06% 205
2018
Q4
$457K Buy
7,400
+4,100
+124% +$282K ﹤0.01% 449
2018
Q3
$253K Hold
3,300
﹤0.01% 499
2018
Q2
$253K Buy
+3,300
New +$247K ﹤0.01% 524

Other funds holding IOSP

Grantham, Mayo, Van Otterloo & Co (GMO)'s IOSP Position: Q2 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Innospec (IOSP) in Q2 2023, closing a stake of 5,600 shares — an estimated $575K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IOSP in Q2 2018 and held it in 17 quarters. The position peaked at $28.1M in Q4 2019. 204 funds tracked by Wall St. Rank hold IOSP as of Q2 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Innospec position as of Q2 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,600 Innospec shares in Q2 2023, an estimated $575K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Innospec in Q2 2018 and held it in 17 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Innospec position peaked at $28.1M in Q4 2019.
  • 204 funds tracked by Wall St. Rank held Innospec as of Q2 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.